| |
| |
|
| Insider
Information: |
Dylan-Hyde Tyler |
| Relationship: |
Chief Legal Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
25,204 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,343,121 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
25,204 |
|
|
| Total
Value |
$1,343,121 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Crispr Therapeutics Ag |
CRSP |
Chief Legal Officer |
2018-01-16 |
25,204 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRSP |
Crispr Therapeutics Ag |
Chief Legal Officer |
• – – |
2018-01-16 |
4 |
AS |
$28.00 |
$1,850,255 |
D/D |
(66,000) |
25,204 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Legal Officer |
• – – |
2018-01-16 |
4 |
OE |
$12.57 |
$263,970 |
D/D |
21,000 |
45,094 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Legal Officer |
• – – |
2018-01-02 |
4 |
AS |
$20.55 |
$822,500 |
D/D |
(38,000) |
70,204 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Legal Officer |
• – – |
2018-01-02 |
4 |
OE |
$12.57 |
$100,560 |
D/D |
8,000 |
78,204 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Legal Officer |
• – – |
2017-12-29 |
4 |
OE |
$12.57 |
$203,909 |
D/D |
15,300 |
124,274 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Legal Officer |
• – – |
2017-12-29 |
4 |
AS |
$21.75 |
$689,055 |
D/D |
(30,300) |
100,204 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Legal Officer |
• – – |
2017-12-28 |
4 |
AS |
$21.75 |
$15,225 |
D/D |
(700) |
115,204 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Legal Officer |
• – – |
2017-12-28 |
4 |
OE |
$14.43 |
$10,101 |
D/D |
700 |
115,904 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Legal Officer |
• – – |
2017-12-22 |
4 |
AS |
$20.55 |
$308,250 |
D/D |
(15,000) |
115,204 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Legal Officer |
• – – |
2017-12-15 |
4 |
AS |
$18.90 |
$283,496 |
D/D |
(15,000) |
130,204 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Legal Officer |
• – – |
2017-08-08 |
4 |
AS |
$18.60 |
$24,422 |
D/D |
(1,313) |
153,204 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Legal Officer |
• – – |
2017-08-07 |
4 |
AS |
$18.56 |
$245,209 |
D/D |
(13,210) |
154,517 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Legal Officer |
• – – |
2017-08-04 |
4 |
AS |
$18.55 |
$8,848 |
D/D |
(477) |
167,727 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Legal Officer |
• – – |
2017-05-01 |
4 |
AS |
$16.61 |
$30,753 |
D/D |
(1,852) |
168,204 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Legal Officer |
• – – |
2017-04-28 |
4 |
AS |
$16.62 |
$81,638 |
D/D |
(4,912) |
170,056 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Legal Officer |
• – – |
2017-04-27 |
4 |
AS |
$16.84 |
$227,799 |
D/D |
(13,527) |
174,968 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Legal Officer |
• – – |
2017-04-26 |
4 |
AS |
$16.76 |
$53,641 |
D/D |
(3,200) |
180,495 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Legal Officer |
• – – |
2017-04-25 |
4 |
AS |
$16.87 |
$80,990 |
D/D |
(4,800) |
183,695 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Legal Officer |
• – – |
2017-04-24 |
4 |
AS |
$16.44 |
$57,897 |
D/D |
(3,522) |
188,495 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Legal Officer |
• – – |
2017-04-21 |
4 |
AS |
$17.02 |
$51,222 |
D/D |
(3,010) |
192,017 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Legal Officer |
• – – |
2017-04-20 |
4 |
AS |
$17.37 |
$51,025 |
D/D |
(2,937) |
195,027 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Legal Officer |
• – – |
2017-04-19 |
4 |
AS |
$17.49 |
$129,165 |
D/D |
(7,240) |
197,964 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Legal OfficerOfficer |
• – – |
2016-10-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
205,204 |
|
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
